• Medientyp: E-Artikel
  • Titel: Pivotal Role of the Lipid Raft SK3–Orai1 Complex in Human Cancer Cell Migration and Bone Metastases
  • Beteiligte: Chantôme, Aurélie; Potier-Cartereau, Marie; Clarysse, Lucie; Fromont, Gaëlle; Marionneau-Lambot, Séverine; Guéguinou, Maxime; Pagès, Jean-Christophe; Collin, Christine; Oullier, Thibauld; Girault, Alban; Arbion, Flavie; Haelters, Jean-Pierre; Jaffrès, Paul-Alain; Pinault, Michelle; Besson, Pierre; Joulin, Virginie; Bougnoux, Philippe; Vandier, Christophe
  • Erschienen: American Association for Cancer Research (AACR), 2013
  • Erschienen in: Cancer Research
  • Sprache: Englisch
  • DOI: 10.1158/0008-5472.can-12-4572
  • ISSN: 0008-5472; 1538-7445
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title> <jats:p>The SK3 channel, a potassium channel, was recently shown to control cancer cell migration, a critical step in metastasis outgrowth. Here, we report that expression of the SK3 channel was markedly associated with bone metastasis. The SK3 channel was shown to control constitutive Ca2+ entry and cancer cell migration through an interaction with the Ca2+ channel Orai1. We found that the SK3 channel triggers an association with the Orai1 channel within lipid rafts. This localization of an SK3–Orai1 complex seemed essential to control cancer cell migration. This suggests that the formation of this complex in lipid rafts is a gain-of-function, because we showed that none of the individual proteins were able to promote the complete phenotype. We identified the alkyl-lipid Ohmline as a disrupting agent for SK3–Orai1 lipid raft localization. Upon Ohmline treatment, the SK3–Orai1 complex moved away from lipid rafts, and SK3-dependent Ca2+ entry, migration, and bone metastases were subsequently impaired. The colocalization of SK3 and Orai1 in primary human tumors and bone metastases further emphasized the clinical relevance of our observations. Targeting SK3–Orai1 in lipid rafts may inaugurate innovative approaches to inhibit bone metastases. Cancer Res; 73(15); 4852–61. ©2013 AACR.</jats:p>
  • Zugangsstatus: Freier Zugang